Moving the Needle in Cervical Cancer Screening: Improving Patient Risk-stratification
Sponsored by Roche
Thursday, April 6
12:00 PM to 1:30 PM
Regency Ballroom U
Lunch will be served to all participants of the symposium
Speakers: Dr. Tom C. Wright, Jr., Dr. Mark Stoler, Dr. Catherine Behrens
In this symposium, Dr. Tom Wright will summarize results from the recently concluded CERTAIN trial, a study of CINtec® Histology* (Immunohistochemical stain for the p16 biomarker). The CERTAIN study is one of the largest cervical biopsy trials ever conducted. Dr. Mark Stoler will present results from a nested sub-study of the ATHENA trial, looking at the performance of CINtec® PLUS Cytology** (dual-stain for p16 and Ki-67) on ThinPrep® Liquid Based Cytology (LBC) specimens. Dr. Catherine Behrens will summarize results from the studies that led to the recent FDA approval of the cobas® HPV Test for use with specimens collected into Surepath™ Liquid Based Cytology Preservative Fluid.
*The CINtec® Histology product is currently under FDA review, and performance claims for this product have not been fully evaluated at the time this program went to press.
**CINtec® PLUS Cytology is not FDA approved for use in the U.S.
If you have any issues with registering using the link above, please contact email@example.com.